Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cushman

Showing results (331-340 of 348) with videos related to

Pageof 35
Sort By:
Journal of Orthopaedics|January 19, 2019
Septic arthritis of the hip and knee treated surgically in pediatric patients: Analysis of the Kids' Inpatient DatabaseMikhail Tretiakov, Frank S Cautela, Sarah E Walker, et al.
The Oncologist|March 15, 2013
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomasHope E Uronis, Johanna C Bendell, Ivy Altomare, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 11, 2020
Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2Hannah M Creager, Barbara Cabrera, Andy Schnaubelt, et al.
Archives of Pathology & Laboratory Medicine|February 7, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical OncologyAntonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
The Journal of Molecular Diagnostics : JMD|February 11, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical OncologyAntonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
American Journal of Clinical Pathology|February 7, 2017
Molecular Biomarkers for the Evaluation of Colorectal CancerAntonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical OncologyAntonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
Journal of Oncology Practice|March 29, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline Summary From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical OncologyAntonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
Investigational New Drugs|April 9, 2014
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumorsFatima Rangwala, Johanna C Bendell, Mark F Kozloff, et al.
Journal of Thrombosis and Haemostasis : JTH|December 16, 2014
Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndromeA Rabinovich, J M Cohen, M Cushman, et al.
Pageof 35

Showing results (331-340 of 348) with videos related to

Sort By:
Pageof 35
Journal of Orthopaedics|January 19, 2019
Septic arthritis of the hip and knee treated surgically in pediatric patients: Analysis of the Kids' Inpatient DatabaseMikhail Tretiakov, Frank S Cautela, Sarah E Walker, et al.
The Oncologist|March 15, 2013
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomasHope E Uronis, Johanna C Bendell, Ivy Altomare, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 11, 2020
Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2Hannah M Creager, Barbara Cabrera, Andy Schnaubelt, et al.
Archives of Pathology & Laboratory Medicine|February 7, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical OncologyAntonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
The Journal of Molecular Diagnostics : JMD|February 11, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical OncologyAntonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
American Journal of Clinical Pathology|February 7, 2017
Molecular Biomarkers for the Evaluation of Colorectal CancerAntonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical OncologyAntonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
Journal of Oncology Practice|March 29, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline Summary From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical OncologyAntonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
Investigational New Drugs|April 9, 2014
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumorsFatima Rangwala, Johanna C Bendell, Mark F Kozloff, et al.
Journal of Thrombosis and Haemostasis : JTH|December 16, 2014
Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndromeA Rabinovich, J M Cohen, M Cushman, et al.
Pageof 35